Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4575132 | 0.88 | FTO (0.34) | FTO | |
| SCHEMBL3776396 | 0.86 | — | — | |
| SCHEMBL215137 | 0.82 | LMNA (0.35) | — | |
| SCHEMBL315867 | 0.81 | FTO (0.45) | FTO | |
| SCHEMBL3747895 | 0.81 | FTO (0.35) | FTO | |
| SCHEMBL2784206 | 0.80 | FTO (0.34) | FTO | |
| SCHEMBL147188 | 0.78 | FTO (0.33) | FTO | |
| SCHEMBL8336070 | 0.75 | FTO (0.32) | FTO | |
| SCHEMBL3977228 | 0.74 | FTO (0.32) | FTO | |
| SCHEMBL4344779 | 0.73 | FTO (0.38) | FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260126387-A1 | IN-SITU DETECTION METHOD FOR REACTIVE OXYGEN SPECIES BASED ON RATIOMETRIC FLUORESCENT PROBE | NANJING UNIVERSITY (CN) | 2026-05-07 | — | — | US | claimed |
| US-20260110698-A1 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | LARIMAR THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12411145-B2 | Methods for quantifying frataxin activity | LARIMAR THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | claimed |
| US-20250085297-A1 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | LARIMAR THERAPEUTICS, INC. | 2025-03-13 | — | — | US | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |
| WO-2024239281-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |
| EP-4426741-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | Hangzhou DAC Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| EP-4426727-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| US-20170173168-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | SUZHOU M-CONJ BIOTECH CO., LTD. (CN) | 2017-06-22 | — | — | US | claimed |
| US-20170143845-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | SUZHOU M-CONJ BIOTECH CO., LTD (CN) | 2017-05-25 | — | — | US | claimed |
| US-20150322155-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | Sushou M-conj Biotech Co., Ltd (CN) | 2015-11-12 | — | — | US | claimed |
| US-20150314017-A1 | DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE | SUZHOU M-CONJ BIOTECH CO., LTD (CN) | 2015-11-05 | — | — | US | claimed |
| US-20150284416-A1 | NOVEL LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | SUZHOU M-CONJ BIOTECH CO., LTD (CN) | 2015-10-08 | — | — | US | claimed |
| WO-2009114895-A1 | DIAGNOSTIC, THERAPEUTIC AND PROPHYLACTIC METHOD AND SCREENING METHOD | THE UNIVERSITY OF SYDNEY (AU) | 2009-09-24 | — | — | WO | claimed |
| EP-2026782-A2 | N1,N4-BIS(BUTA-1,3-DIENYL)BUTANE-1,4-DIAMINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Wisconsin Alumini Research Foundation (US) | 2009-02-25 | — | — | EP | claimed |
| US-20080114072-A1 | Antioxidants; polyamine oxidase inhibitors; for preventing and/or treating prostate cancer in male humans; kits | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-05-15 | — | — | US | claimed |
| WO-2007130589-A2 | NL, N4-BIS (BUTA-I, 3-DIENYL) BUTANE-I, 4-DIAMINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-11-15 | — | — | WO | claimed |
| US-20040126891-A1 | Method for assaying reactive oxidants in smoke | BRUNSWICK LABORATORIES | 2004-07-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284416-A1 | NOVEL LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | EPCAM, CD2BP2, CD44 | FTO 4850/4885 |
| US-20260110698-A1 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | ATXN2L, XDH, CYFIP1 | FTO 2876/4885 |
| US-20170173168-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | AADAC, EPCAM, DCLRE1A | FTO 4732/4885 |
| US-20170143845-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | AADAC, EPCAM, DCLRE1A | FTO 4732/4885 |
| US-20080114072-A1 | Antioxidants; polyamine oxidase inhibitors; for preventing and/or treating prostate cancer in male humans; kits | BPHL, AOC1, DDO | FTO 1190/4885 |
| US-20150322155-A1 | ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE | DCLRE1A, AADAC, UACA | FTO 4499/4885 |
| US-20260126387-A1 | IN-SITU DETECTION METHOD FOR REACTIVE OXYGEN SPECIES BASED ON RATIOMETRIC FLUORESCENT PROBE | CYBA, NOX4, IK | FTO 658/4885 |
| US-20150314017-A1 | DISULFUR BRIDGE LINKERS FOR CONJUGATION OF A CELL-BINDING MOLECULE | CD74, CD2, EPCAM | FTO 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.